Miguel Forte, CEO of Kiji Therapeutics, and Tony Ting, CSO, will attend the ISCT Annual Congress in Vancouver, Canada, May 29-June 1, 2024.
Both have been involved in the organization of the event and will participate as moderators of several sessions throughout the congress.
In addition, on Thursday, May 30th, Dr. Tony Ting will present poster number 188 showing the latest results obtained by Kiji Therapeutics in collaboration with CIEMAT on the efficacy of cryopreserved CXCR4-IL10-MSCs in a xenogeneic model of GvHD.